• Publications
  • Influence
Drug-induced liver injury: recent advances in diagnosis and risk assessment
Idiosyncratic drug-induced liver injury (IDILI) is a rare but potentially severe adverse drug reaction that should be considered in patients who develop laboratory criteria for liver injury secondaryExpand
  • 158
  • 3
  • PDF
Lipid Lowering Therapy with Fluvastatin and Pravastatin in Patients with HIV Infection and Antiretroviral Therapy: Comparison of Efficacy and Interaction with Indinavir
Abstract.Background:Lipoprotein disorders in HIV-positive patients receiving highly active antiretroviral therapy (HAART) are becoming a major concern in HIV treatment, since there is growingExpand
  • 58
  • 3
Plasma cystatin C is a predictor of renal dysfunction, acute‐on‐chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis
The development of acute‐on‐chronic liver failure (ACLF) in patients with liver cirrhosis is associated with high mortality rates. Renal failure is the most significant organ dysfunction that occursExpand
  • 34
Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury
Background Idiosyncratic drug-induced liver injury (iDILI) is a frequent cause of acute liver injury and a serious problem in late stage drug-development. Its diagnosis is one of the most challengingExpand
  • 28
Serum Neutrophil Gelatinase-Associated Lipocalin – A Sensitive Novel Marker of Renal Impairment in Liver Cirrhosis?
Recently, neutrophil gelatinase-associated lipocalin (NGAL) has been introduced as a sensitive and early marker of acute kidney injury [5] . NGAL in cirrhosis and chronic renal failure has not beenExpand
  • 19
  • PDF
Drug-Induced Liver Injury and Individual Cell Models
Drug-induced liver injury (DILI) is the most common cause of acute liver failure and accounts for the majority of regulatory actions on drugs. Furthermore, DILI is a relevant cause for projectExpand
  • 7
  • PDF
Development and Validation of a Test to Identify Drugs That Cause Idiosyncratic Drug‐Induced Liver Injury
Background & Aims Idiosyncratic drug‐induced liver injury (iDILI) is one of the most challenging diagnoses in hepatology. It is frequently impossible to identify the agent that has caused iDILI inExpand
  • 20
  • PDF
Proteomics Analysis of Monocyte-Derived Hepatocyte-Like Cells Identifies Integrin Beta 3 as a Specific Biomarker for Drug-Induced Liver Injury by Diclofenac
Idiosyncratic drug-induced liver injury (iDILI) is a major cause of acute liver failure resulting in liver transplantation or death. Prediction and diagnosis of iDILI remain a great challenge, asExpand
  • 7
  • PDF
Liquid chromatographic method for the determination of uridine in human serum.
To evaluate uridine levels in humans we developed a very sensitive and specific high-performance liquid chromatographic method for the determination of uridine in serum. We use techniques which areExpand
  • 6
Drug-Drug Combinations can Enhance Toxicity as shown by Monocyte-Derived Hepatocyte-like Cells from Patients with Idiosyncratic Drug-Induced Liver Injury.
BACKGROUND Drug-induced liver injury (DILI) is a major cause for acute liver failure and regulatory actions on novel drugs. Individual patient characteristics are the main determinant ofExpand
  • 2